GNH USA

Europe — EMA

Nulojix (Belatacept)

Belatacept, the active ingredient in Nulojix, is an immunosuppressant presented as a unknown/Intravenous infusion for IV use. It is used to prevent organ rejection in adult kidney transplant recipients.

Request sourcing

1
Pack/s

What is Belatacept?

Belatacept, the active ingredient in Nulojix, is an immunosuppressant presented as a unknown/Intravenous infusion for IV use. It is used to prevent organ rejection in adult kidney transplant recipients. GNH USA supplies Nulojix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Nulojix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

What is Belatacept used for?

Nulojix is an immunosuppressive agent that is used in transplantation medicine:

- Kidney transplant:    ​  It   ​  ​  ...  ....  …  ....  …  ...  ...  ....  ...  ...  ...  ...  ... …  ....  ...  … . -    …  …  ...  …  ...

What are the side effects of Belatacept?

Common        …  … … … … … … … 

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Belatacept
Route
Intravenous Use
Manufacturer
Bristol-Myers Squibb Pharma Eeig
Origin
EU

Related products